# Crick-UCLH-Legacy-Monoclonals-2022-10
Data and analysis scripts for Wu _et al._, _Lancet_, 2022.

"Clinical and in vitro evidence support reassessment of WHO Living Guideline on monoclonal antibody therapy for COVID-19"

LINK

Please cite:

CITATION

***

This publication is a third analysis of the Crick/UCLH Legacy study, and builds on previously published work:

"AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC"

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01462-8/fulltext

and incorporating data from Wall, Wu, _et al._, _Lancet_, 2021.

"Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination"

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01290-3/fulltext

These may also be cited as:

Wall EC, Wu M, Harvey R, Kelly G, Warchal S, Sawyer C, Daniels R, Adams L, Hobson P, Hatipoglu E, Ngai Y, Hussain S, Ambrose K, Hindmarsh S, Beale R, Riddell A, Gamblin S, Howell M, Kassiotis G, Libri V, Williams B, Swanton C, Gandhi S, Bauer DL. AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC. Lancet. 2021 Jul 17;398(10296):207-209. doi: 10.1016/S0140-6736(21)01462-8. Epub 2021 Jun 28. PMID: 34197809; PMCID: PMC8238446.

AND 

Wall EC, Wu M, Harvey R, Kelly G, Warchal S, Sawyer C, Daniels R, Hobson P, Hatipoglu E, Ngai Y, Hussain S, Nicod J, Goldstone R, Ambrose K, Hindmarsh S, Beale R, Riddell A, Gamblin S, Howell M, Kassiotis G, Libri V, Williams B, Swanton C, Gandhi S, Bauer DLV. Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination. Lancet. 2021 Jun 19;397(10292):2331-2333. doi: 10.1016/S0140-6736(21)01290-3. Epub 2021 Jun 3. PMID: 34090624; PMCID: PMC8175044.

***

Available in this repository:
 * LegacyOmicron_19jan2022_PUBLIC.Rdata
 * Crick_Legacy_Omicron1_2022-01-19_generatePlots.R
